Acne: Causes, treatment and myths

Dermatology Research Focus on Acne, Melanoma and Psoriasis

Volumn , Issue , 2010, Pages 97-106

  Muizzuddin, Neelam ^a  

^a Estee Lauder Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85048136881     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (49)

1. Holland, KT; Cunliffe, WJ; Roberts, CD. The role of bacteria in acne vulgaris-a new approach. Clin Exp Dermatol, 1978, 3, 253-257.
2. Holmes, RL; Willimas, M; Cunliffe, WJ. Pilosebaceous duct obstruction and acne. Br J Dermatol, 1972, 87, 327-332.
3. Toyoda, M; Morohashi, M. Pathogenesis of acne. Med Electron Microsc, 2001 Mar, 34(1), 29-40.
4. Leyden, JJ. Antibiotic resistance in the topical treatment of acne vulgaris. Cutis, 2004 Jun, 73(6 Suppl), 6-10.
5. Leyden, JJ. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Cutis, 2002 Jun, 69(6), 475-480.
6. Kligman, AM. The growing importance of topical retinoids in clinical dermatology: a retrospective and prospective analysis. J Am Acad Dermatol, 1998 Aug, 39(2 Pt 3), S2-7.
7. Levell, MJ; Cawood, ML; Burke, B; et al. Acne is not associated with abnormal plasma androgens. Br J Dermatol, 1989, 120, 649-54.
8. Thiboutot, D; Gilliland, K; Light, J; Lookingbill, D. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol, 1999, 135, 1041-1045.
9. Zouboulis, CC. Acne and sebaceous gland function. Clin Dermatol, 2004 Sep-Oct, 22(5), 360-366.
10. Zouboulis, CC. Human Skin: An Independent Peripheral Endocrine Organ. Horm Res, 2000, 54, 230-242.
11. Toyoda, M; Morohashi, M. New aspects in acne inflammation. Dermatology, 2003, 206(1), 17-23.
12. Lavker, RM; Leyden, JJ; McGinley, KJ. The relationship between bacteria and the abnormal follicular keratinization in acne vulgaris. J Invest Dermatol, 1981 Sep, 77(3), 325-330.
13. Gollnick, H. Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs, 2003, 63(15), 1579-96.
14. Buchner, SA. Acne and its drug treatment. Ther Umsch, 1990 Aug, 47(8), 670-674.
15. Dogra, A; Sood, VK; Minocha, YC. Comparative evaluation of retinoic acid, benzoyl peroxide and erythromycin lotion in acne vulgarils Indian J of Derm, venerology and leprology, 1993, 59(5), 243-246.
16. Tanghetti, E. The evolution of benzoyl peroxide therapy. Cutis, 2008 Nov, 82(5 Suppl), 5-11.
17. Haustein, UF; Tegetmeyer, L; Ziegler, V. Allergic and irritant potential of benzoyl peroxide. Contact Dermatitis, 1985, 13, 252-257.
18. Franz, E; Weidner-Strahl, S. The effectiveness of topical antibacterials in acne: a double-blind clinical study. J Int Med Res, 1978, 6(1), 72-77.
19. Lee, TW; Kim, JC; Hwang, SJ. Hydrogel patches containing triclosan for acne treatment. Eur J Pharm Biopharm, 2003 Nov, 56(3), 407-412.
20. Stoughton, RB; Leyden, JJ. Efficacy of 4 percent chlorhexidine gluconate skin cleanser in the treatment of acne vulgaris. Cutis, 1987 Jun, 39(6), 551-3.
21. Worret, WI; Fluhr, JW. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges, 2006 Apr, 4(4), 293-300.
22. Del Rosso, JQ; Kim, G. Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin., 2009 Jan, 27(1), 33-42.
23. Guay, DR. Topical clindamycin in the management of acne vulgaris. Expert Opin Pharmacother, 2007 Oct, 8(15), 2625-2664.
24. Gupta, AK; Lynde, CW; Kunynetz, RA; Amin, S; Choi, K; Goldstein, E. A Randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. J Cutan Med Surg, 2003 Jan-Feb, 7(1), 31-37.
25. Adişen, E; Kaymak, Y; Gurer, MA; Durakan, E. Topical tetracycline in the treatment of acne vulgaris. J Drugs Dermatol, 2008 Oct, 7(10), 953-955.
26. Akman, A; Durusoy, C; Senturk, M; Koc, CK; Soyturk, D; Alpsoy, E. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res, 2007 Dec, 299(10), 467-473. Epub 2007 Aug 21.
27. Bener A, Lestringant GG, Ehlayel MS, Saarinen K, Takiddin AH. Treatment Outcome of Acne Vulgaris with Oral Isotretinoin. J Coll Physicians Surg Pak, 2009 Jan, 19(1), 49-51.
28. Bensouda-Grimaldi, L; Jonville-Béra, AP; Mouret, E; Elefant, E; Dhellot, H; Delmas, C; Gouin, T; Coste, P; Autret-Leca, E. Isotretinoin: compliance with recommendations in childbearing women. Ann Dermatol Venereol, 2005 May, 132(5), 415-23.
29. Mills, JP; Terasawa, E; Tanumihardjo, SA. Ingestion of excessive preformed vitamin A by mothers amplifies storage of retinyl esters in early fetal livers of captive Old World monkeys. Comp Med, 2007, 57, 505-511.
30. Mukherjee, S; Date, A; Patravale, V; Korting, HC; Roeder, A; Weindl, G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging, 2006, 1, 327-348.
31. Thielitz, A; Gollnick, H. Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol, 2008, 9(6), 369-81.
32. Mantle, D; Gok, MA; Lennard, TW. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse drug reactions and toxicological reviews, 2001, 20(2), 89-103.
33. Jain, A; Basal, E. Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs. Phytomedicine, 2003, 10(1), 34-38.
34. Shalita, AR; Smith, JG; Parish, LC; Sofman, MS; Chalker, DK. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int. J. Dermatol, 1995 June, 34(6), 434-437.
35. Koh, KJ; Pearce, AL; Marshman, G; Finlay-Jones, JJ; Hart, PH. Tea tree oil reduces histamine-induced skin inflammation. Br. J. Dermatol, 2002, 147(6), 1212-1217.
36. Muizzuddin, N; Giacomoni, P; Maes, D. Acne - a multifaceted problem in Drug Discovery Today in, Editors, Toren Finkel and Charles Lowenstein, Disease Mechanisms, Amsterdam, The Netherlands, 2008, 5(2), e183-e188.
37. Klaz, I; Kochba, I; Shohat, T; Zarka, S; Brenner, S. Severe acne vulgaris and tobacco smoking in young men. J Invest Dermatol, 2006 Aug, 126(8), 1749-1752.
38. Rombouts, S; Nijsten, T; Lambert, J. Cigarette smoking and acne in adolescents: results from a cross-sectional study. J Eur Acad Dermatol Venereol, 2007 Mar, 21(3), 326-333.
39. Kimball, AB. Advances in the treatment of acne. J Reprod Med, 2008 Sep, 53(9 Suppl), 742-752.
40. Gfesser, M; Worret, WI. Seasonal variations in the severity of acne vulgaris. Int J Dermatol, 1996 Feb, 35(2), 116-117.
41. Al-Ameer, AM; Al-Akloby, OM. Demographic features and seasonal variations in patients with acne vulgaris in Saudi Arabia: a hospital-based study. Int J Dermatol, 2002 Dec, 41(12), 870-871.
42. Sardana, K; Sharma, RC; Sarkar, R. Seasonal variation in acne vulgaris--myth or reality. J Dermatol., 2002 Aug, 29(8), 484-488.
43. Ammad, S; Gonzales, M; Edwards, C; Finlay, AY; Mills, C. An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris. J Cosmet Dermatol, 2008 Sep, 7(3), 180-188.
44. Kjeldstad, B. Photoinactivation of Propionibacterium acnes by near-ultraviolet light. Z Naturforsch [C], 1984, 39 (3-4), 300-302.
45. Ashkenazi, H; Malik, Z; Harth, Y; Nitzan, Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol, 2003, 35(1), 17-24.
46. Papageorgiou, P; Katsambas, A; Chu, A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol, 2000, 142(5), 973-978.
47. Xu, SX; Wang, HL; Fan, X; Sun, LD; Yang, S; Wang, PG; Xiao, FL; Gao, M; Cui, Y; Ren, YQ; Du, WH; Quan, C; Zhang, XJ. The familial risk of acne vulgaris in Chinese Hans - a case-control study. J Eur Acad Dermatol Venereol, 2007 May, 21(5), 602-605.
48. Cordain, L. Implications for the Role of Diet in Acne. Semin Cutan Med Surg, 2005, 24, 84-91.
49. Berrino, F; Bellati, C; Secreto, G; Camerini, E; Pala, V; Panico, S; Allegro, G; Kaaks, R. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev, 2001, 10, 25-33.